ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CEL Celadon Pharmaceuticals Plc

19.00
0.00 (0.00%)
Last Updated: 08:00:02
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 19.00 17.00 21.00 19.00 19.00 19.00 6,589 08:00:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 149k -7.14M -0.1078 -1.76 12.58M
Celadon Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 19p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 12.50p to 127.50p.

Celadon Pharmaceuticals currently has 66,220,807 shares in issue. The market capitalisation of Celadon Pharmaceuticals is £12.58 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.76.

Celadon Pharmaceuticals Share Discussion Threads

Showing 6826 to 6841 of 6875 messages
Chat Pages: 275  274  273  272  271  270  269  268  267  266  265  264  Older
DateSubjectAuthorDiscuss
23/8/2024
12:36
"Dog" is too polite and rude to dogs, which are lovely.

This is a stinking cess pit of a foul smelling scam.

jaknife
23/8/2024
11:44
Avoid this dog
blakesmith
20/8/2024
08:05
I am presuming some finance is sorted or else it’s a scandal this has been allowed to trade as long as it has, following that RNS.
talk2dubya
15/8/2024
14:48
Cannot beat a bit of death spiral financing.
talk2dubya
13/8/2024
11:53
Riverfort is about to enter the scene.


Enjoy !!


Regards,
F911
RMC

firestorm911
13/8/2024
11:12
F911 is proudly reducing the target price from 1p to 0.000911p.

Good shs to short.

Enjoy !!

Regards,
F911
RMC

firestorm911
12/8/2024
08:31
Celadon informs the market that:

1. It hasn't received all of cash from the May placing (three months after!),

2. It hasn't received the cash from the loan announced in May, and

3. It only has £48k of cash left before it's lights off time

jaknife
09/8/2024
13:38
Spot on again, JakNife.
papillon
17/7/2024
07:55
a 1p stock?

It's a scam with fake contract.

This will be joining the famous -99% club.


Regards,
F911
RMC

firestorm911
03/7/2024
09:50
talk2dubya,

"Well the facilities alone are worth 60m. Nice update"

I'm afraid that whomever told you that was taking advantage of your naivety.

The accounts are quite clear:



CEL has invested less than £3m into its "facilities", which are loss-making.

JakNife

jaknife
03/7/2024
09:35
I don’t think I have ever held a share as poor as this, in terms of shareholder engagement and newsflow.
talk2dubya
23/5/2024
10:14
can't see any reason to value this at more than the book value of £3.2m, especially bearing in mind that they obviously need to raise funds again

Well the facilities alone are worth 60m. Nice update

talk2dubya
22/5/2024
20:02
Its funny investors keep committing money at above the market price when the vast majority have to raise at huge discounts. Somebody can see a big return here, could they be right?
czar
10/5/2024
06:59
These new investors want in to CEL and are happy to pay the offer price, that speaks volumes for what they know about this business.
czar
07/3/2024
13:27
Looks like a pretty significant RNS to me this. Market seems to have missed it, have bought a few today.

Is this not significant, the part about the GP’s?
gives us even greater confidence in our forthcoming clinical trial, which will involve up to 5,000 patients and see General Practitioners permitted to prescribe cannabis-based medicines

talk2dubya
12/12/2023
14:19
This looks to be yet another UK Company that is achieving excellent progress but is massively undervalues on AIM. It has to either rerate, be taken over or move to another exchange. The last UK business with similar credentials was GW Pharma and that got bought for $7.2 billion.
czar
Chat Pages: 275  274  273  272  271  270  269  268  267  266  265  264  Older

Your Recent History

Delayed Upgrade Clock